14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CLLS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Is Cellectis S.A. stock still a buy after falling -7.46% on Tuesday?
(Updated on May 07, 2024)

Buy candidate since May 07, 2024 PDF

The Cellectis S.A. stock price fell by -7.46% on the last day (Tuesday, 7th May 2024) from $3.35 to $3.10. During the last trading day the stock fluctuated 8.50% from a day low at $2.94 to a day high of $3.19. The price has been going up and down for this period, and there has been a 18.33% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -29 thousand shares and in total, 243 thousand shares were bought and sold for approximately $753.86 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.51% during the next 3 months and, with a 90% probability hold a price between $2.30 and $3.26 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CLLS Signals & Forecast

The Cellectis S.A. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.87 and $2.65. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, May 06, 2024, and so far it has fallen -7.46%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Cellectis S.A. stock

Cellectis S.A. finds support from accumulated volume at $2.99 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.250 between high and low, or 8.50%. For the last week the stock has had daily average volatility of 7.79%.

Our recommended stop-loss: $2.93 (-5.56%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (CLLS) For The Upcoming Trading Day Of Wednesday 8th

For the upcoming trading day on Wednesday, 8th we expect Cellectis S.A. to open at $3.08, and during the day (based on 14 day Average True Range), to move between $2.89 and $3.31, which gives a possible trading interval of +/-$0.206 (+/-6.65%) up or down from last closing price. If Cellectis S.A. takes out the full calculated possible swing range there will be an estimated 13.31% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.99 (3.55%) than the resistance at $3.35 (8.06%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Cellectis S.A. will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.330. We will update the financials statements for Cellectis S.A., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 6.41% in the first trading day after earnings release.

Is Cellectis S.A. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 1.405 Buy Candidate Upgraded

Predicted Opening Price for Cellectis S.A. of Wednesday, May 8, 2024

Fair opening price May 8, 2024 Current price
$3.08 ( 0.753%) $3.10

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CLLS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.33 7.31 %
R2 3.23 4.23 %
R1 3.17 2.33 %
Current price: 3.10
Support S1 2.98 -3.83 %
S2 2.92 -5.74 %
S3 2.83 -8.82 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 3.35 8.06 %
Current price 3.10
Support S1 2.99 -3.55%
S2 2.69 -13.23%
S3 2.51 -19.17%

FAQ

What is the symbol for Cellectis S.A. Stock and on which exchange is it traded?
The symbol for Cellectis S.A. is CLLS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cellectis S.A. Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy Cellectis S.A. Stock?
Cellectis S.A. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cellectis S.A. Stock.

What's the current price of Cellectis S.A. Stock?
As of the end of day on the May 07, 2024, the price of an Cellectis S.A. (CLLS) share was $3.10.

What is the 52-week high and low for Cellectis S.A. Stock?
The 52-week high for Cellectis S.A. Stock is $133.42 and the 52-week low is $97.83.

What is the market capitalization of Cellectis S.A. Stock?
As of the May 07, 2024, the market capitalization of Cellectis S.A. is 222.429M.

When is the next earnings date for Cellectis S.A.?
The upcoming earnings date for Cellectis S.A. is May 09, 2024.
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT